Novonesis's market cap is currently $23.82B. The company's EPS TTM is €0.40991136406; its P/E ratio is 75.58; Novonesis is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is €0.76. See an overview of income statement, balance sheet, and cash flow financials.
